Work

Prognostic Factors for Survival in Multiple Myeloma Patients That Receive Bispecific Antibodies: Does Relative Dose Intensity Matters?

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-211033

Authors: Henry Becerra, Emmanuel Bugarin-Estrada, Ruben Niesvizky, Roger Pearse, Jorge Monge, Mateo Mejia Saldarriaga

Institutions: Brookdale University Hospital and Medical Center, University of Miami Health System, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405043038

Cites:

Cited by:

Related to: 10